S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Closing prices for crude oil, gold and other commodities
KB Home Strong Results Lift Prices
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Trump arrested? Putin jailed? Fake AI images spread online
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Lawsuit: Slurs, coercion at BBQ chain with racist history
Coinbase tumbles after SEC warns of securities violations
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Closing prices for crude oil, gold and other commodities
KB Home Strong Results Lift Prices
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Trump arrested? Putin jailed? Fake AI images spread online
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Lawsuit: Slurs, coercion at BBQ chain with racist history
Coinbase tumbles after SEC warns of securities violations
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Closing prices for crude oil, gold and other commodities
KB Home Strong Results Lift Prices
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Trump arrested? Putin jailed? Fake AI images spread online
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Lawsuit: Slurs, coercion at BBQ chain with racist history
Coinbase tumbles after SEC warns of securities violations
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Closing prices for crude oil, gold and other commodities
KB Home Strong Results Lift Prices
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Trump arrested? Putin jailed? Fake AI images spread online
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Free Stock Analysis Report: Get Buy, Sell, or Hold Recommendation (Ad)pixel
Lawsuit: Slurs, coercion at BBQ chain with racist history
Coinbase tumbles after SEC warns of securities violations
OTCMKTS:TRSBF

3SBio - TRSBF Stock Forecast, Price & News

$0.80
0.00 (0.00%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.80
$0.80
50-Day Range
$0.80
$0.80
52-Week Range
$0.80
$0.80
Volume
N/A
Average Volume
63,275 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About 3SBio

3SBio Inc., an investment holding company, researches, develops, manufactures, markets, and sells biopharmaceutical products in the People's Republic of China. The company provides TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombopenia and immune thrombocytopenia; YISAIPU, a tumor necrosis factor for rheumatoid arthritis, ankylosing spondylitis, and psoriasis; EPIAO and SEPO recombinant human erythropoietins to treat anemia; and Cipterbin for HER2-positive metastatic breast cancer in combination with chemotherapy. It also offers Mandi to treat male alopecia and alopecia areata; Xenopax for preventing acute rejection after renal transplant; Byetta for the glycemic control in patients with type 2 diabetes; Qiming Keli to treat retinopathy caused by type 2 diabetic; Aiyishu for iron-deficiency anemia; and SPARIN, an injectable low-molecular-weight heparin calcium for the treatment of prophylaxis and deep vein thrombosis, as well as for the prevention of clotting during hemodialysis. In addition, it offers Intefen, a recombinant human interferon to treat lymphatic or hematopoietic malignancies and viral infections; and Inleusin, a human interleukin2 for the treatment of renal cell carcinoma, melanoma, and thoracic fluid build-up. Further, the company provides trading, project management and consultation, technology, and agricultural services. It has collaboration agreements with companies, such as AstraZeneca, Lilly, Toray Industries Inc, Samsung Bioepis, Refuge Biotechnologies, Verseau, TLC, Numab, GenSight, Sensorion, and Dana-Farber Cancer Institute. The company was founded in 1993 and is headquartered in Shenyang, the People's Republic of China.

Receive TRSBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 3SBio and its competitors with MarketBeat's FREE daily newsletter.

TRSBF Stock News Headlines

Short Interest in 3SBio Inc. (OTCMKTS:TRSBF) Drops By 11.1%
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
See More Headlines
Receive TRSBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 3SBio and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TRSBF
CIK
N/A
Fax
N/A
Employees
5,292
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Jing Lou M.D. (Age 59)
    Ph.D., Co-Founder, Exec. Chairman, CEO & Pres
    Comp: $617.76k
  • Dr. Dongmei Su (Age 52)
    Sr. VP & Exec. Director
    Comp: $206.49k
  • Mr. Fei Wang (Age 44)
    Chief Financial Officer
  • Ms. Lu Xia (Age 37)
    Director of Investor Relations
  • Ms. Hui Dang (Age 50)
    Director of Risk and Compliance Management
  • Mr. Thomas Folinsbee C.F.A. (Age 54)
    CFA, Director of Corp. Devel.
  • Mr. Xin Ma (Age 56)
    VP of the HR Department
  • Ms. Siu Kuen Lai FCIS (Age 46)
    FCS, Company Sec.
  • Ms. Fei You (Age 43)
    Director of the Fin. Department & Financial Controller
  • Mr. Junlin Wang (Age 49)
    Pres of Guojian













TRSBF Stock - Frequently Asked Questions

How have TRSBF shares performed in 2023?

3SBio's stock was trading at $0.80 on January 1st, 2023. Since then, TRSBF shares have increased by 0.0% and is now trading at $0.80.
View the best growth stocks for 2023 here
.

Are investors shorting 3SBio?

3SBio saw a decline in short interest in February. As of February 28th, there was short interest totaling 4,971,500 shares, a decline of 11.1% from the February 13th total of 5,590,900 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.
View 3SBio's Short Interest
.

What is 3SBio's stock symbol?

3SBio trades on the OTCMKTS under the ticker symbol "TRSBF."

How do I buy shares of 3SBio?

Shares of TRSBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is 3SBio's stock price today?

One share of TRSBF stock can currently be purchased for approximately $0.80.

How many employees does 3SBio have?

The company employs 5,292 workers across the globe.

How can I contact 3SBio?

3SBio's mailing address is Shenyang Economy & Tech Development, Shenyang, Liaoning 110027. The official website for the company is www.3sbio.com. The company can be reached via phone at 86 24 2538 6000.

This page (OTCMKTS:TRSBF) was last updated on 3/24/2023 by MarketBeat.com Staff